These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 17136689)
21. Insulin resistance is associated with increased cardiovascular risk in Asian Indians with normal glucose tolerance--the Chennai Urban Rural Epidemiology Study (CURES-66). Sandeep S; Gokulakrishnan K; Deepa M; Mohan V J Assoc Physicians India; 2011 Aug; 59():480-4. PubMed ID: 21887902 [TBL] [Abstract][Full Text] [Related]
22. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Bonora E; Tessari R; Micciolo R; Zenere M; Targher G; Padovani R; Falezza G; Muggeo M Diabetes Care; 1997 Apr; 20(4):627-31. PubMed ID: 9096992 [TBL] [Abstract][Full Text] [Related]
23. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? Osei K; Rhinesmith S; Gaillard T; Schuster D J Clin Endocrinol Metab; 2003 Oct; 88(10):4596-601. PubMed ID: 14557428 [TBL] [Abstract][Full Text] [Related]
24. Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Jepson C; Hsu JY; Fischer MJ; Kusek JW; Lash JP; Ricardo AC; Schelling JR; Feldman HI; Am J Kidney Dis; 2019 Jan; 73(1):72-81. PubMed ID: 30177484 [TBL] [Abstract][Full Text] [Related]
25. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE; Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207 [TBL] [Abstract][Full Text] [Related]
26. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD. Navaneethan SD; Schold JD; Jolly SE; Arrigain S; Winkelmayer WC; Nally JV Am J Kidney Dis; 2017 Aug; 70(2):191-198. PubMed ID: 28196649 [TBL] [Abstract][Full Text] [Related]
27. Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives. Abdullah K; Al-Habori M; Al-Eryani E Biomed Res Int; 2020; 2020():1281792. PubMed ID: 32775407 [TBL] [Abstract][Full Text] [Related]
28. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. Shinohara K; Shoji T; Emoto M; Tahara H; Koyama H; Ishimura E; Miki T; Tabata T; Nishizawa Y J Am Soc Nephrol; 2002 Jul; 13(7):1894-900. PubMed ID: 12089386 [TBL] [Abstract][Full Text] [Related]
29. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Wang S; Shi J; Peng Y; Fang Q; Mu Q; Gu W; Hong J; Zhang Y; Wang W Cardiovasc Diabetol; 2021 Apr; 20(1):82. PubMed ID: 33888131 [TBL] [Abstract][Full Text] [Related]
30. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017 [TBL] [Abstract][Full Text] [Related]
31. The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population. Gui MH; Qin GY; Ning G; Hong J; Li XY; Lü AK; Shen WF; Gao X Diabetes Res Clin Pract; 2009 Aug; 85(2):213-9. PubMed ID: 19501926 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Fasting Glucose-Insulin-C-Peptide-Derived Metabolic Indices for Identifying Metabolic Syndrome in Young, Healthy Adults. Kosovski IB; Ghiga D; Ciurea CN; Cucoranu DC; Demian L; Gliga FI; Bacârea A Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999882 [TBL] [Abstract][Full Text] [Related]
33. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients. Tonbul HZ; Turkmen K; Kayıkcıoglu H; Ozbek O; Kayrak M; Biyik Z Ren Fail; 2011; 33(8):770-5. PubMed ID: 21770856 [TBL] [Abstract][Full Text] [Related]
34. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590 [TBL] [Abstract][Full Text] [Related]
35. Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients. Niemczyk S; Szamotulska K; Giers K; Jasik M; Bartoszewicz Z; Romejko-Ciepielewska K; Paklerska E; Gomółka M; Matuszkiewicz-Rowińska J Med Sci Monit; 2013 Jul; 19():592-8. PubMed ID: 23867834 [TBL] [Abstract][Full Text] [Related]
36. The Effect of Iranian Propolis on Glucose Metabolism, Lipid Profile, Insulin Resistance, Renal Function and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Clinical Trial. Zakerkish M; Jenabi M; Zaeemzadeh N; Hemmati AA; Neisi N Sci Rep; 2019 May; 9(1):7289. PubMed ID: 31086222 [TBL] [Abstract][Full Text] [Related]
37. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio. Yang M; Zhou X; Xu J; Yang B; Yu J; Gong Q; Zhang X; Sun X; Zhang Q; Xia J; Li J Bosn J Basic Med Sci; 2019 Nov; 19(4):328-335. PubMed ID: 31078135 [TBL] [Abstract][Full Text] [Related]
38. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010 [TBL] [Abstract][Full Text] [Related]
39. Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Lirussi F; Beccarello A; Zanette G; De Monte A; Donadon V; Velussi M; Crepaldi G Diabetes Nutr Metab; 2002 Aug; 15(4):222-31. PubMed ID: 12416659 [TBL] [Abstract][Full Text] [Related]
40. Association Between Insulin Resistance and the Inflammatory Marker C-reactive Protein in a Representative Healthy Adult Canadian Population: Results From the Canadian Health Measures Survey. Shahid R; Chu LM; Arnason T; Pahwa P Can J Diabetes; 2023 Jul; 47(5):428-434. PubMed ID: 36996968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]